Simplifying Global Compliance
AstraZeneca Settles Toprol XL Lawsuit for $11 Million
AstraZeneca and affiliates will pay as much as $11 million to settle claims the company violated antitrust and consumer-protection laws by keeping generic versions of the heart drug Toprol XL off the market.
Copyright ©2014. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing